Pediatric Bioequivalence Studies Are Unnecessary, FDA Says In Rejecting Nycomed Petition
This article was originally published in The Pink Sheet Daily
Executive Summary
Nycomed had sought additional approval requirements for generic versions of its atopic dermatitis lotion Cutivate.